Coagadex
Coagadex ingredients
| Active ingredient | Strength |
|---|---|
| Coagulation factor x human | see label |
What Coagadex is used for
The FDA lists the approved uses on the official label (below). In the EU, human coagulation factor X is approved as Coagadex for:
Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is indicated in all age groups.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Coagadex
- Generic name
- Coagulation factor x human
- Made by
- Bio Products Laboratory Ltd
- Forms
- Kit
- FDA approval
- Biologic licence (BLA) BLA125506
- On the US market since
- 2015
Official information
- Coagadex prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Coagulation factor x human)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Coagadex?
Coagadex (Coagulation factor x human) is a specialist medicine made by Bio Products Laboratory Ltd, approved by the US FDA.
What are the ingredients of Coagadex?
Coagadex contains Coagulation factor x human.
Is Coagadex approved in Europe?
The same active substance is approved in the EU as Coagadex.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA